BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 8435100)

  • 1. Antiplatelet activity of some prenylflavonoids.
    Lin CN; Shieh WL; Ko FN; Teng CM
    Biochem Pharmacol; 1993 Jan; 45(2):509-12. PubMed ID: 8435100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets.
    Yu SM; Chen CC; Ko FN; Huang YL; Huang TF; Teng CM
    Biochem Pharmacol; 1992 Jan; 43(2):323-9. PubMed ID: 1310852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of collagen-induced platelet aggregation and adhesion by a pseudocyanide derivative of avicine isolated from Zanthoxylum integrifoliolum Merr.
    Ko FN; Hsiao G; Chen IS; Wu SJ; Teng CM
    Biochem Pharmacol; 1993 Oct; 46(7):1165-73. PubMed ID: 8216367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet actions of some coumarin compounds isolated from plant sources.
    Teng CM; Li HL; Wu TS; Huang SC; Huang TF
    Thromb Res; 1992 Jun; 66(5):549-57. PubMed ID: 1523611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of platelet aggregation by some flavonoids.
    Tzeng SH; Ko WC; Ko FN; Teng CM
    Thromb Res; 1991 Oct; 64(1):91-100. PubMed ID: 1776142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bakkenolide G, a natural PAF-receptor antagonist.
    Liao CH; Ko FN; Wu TS; Teng CM
    J Pharm Pharmacol; 1997 Dec; 49(12):1248-53. PubMed ID: 9466352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound.
    Ding YA; Chou TC; Chern JW; Yen MH
    Thromb Res; 1995 Feb; 77(3):291-303. PubMed ID: 7740521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
    Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
    Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tea polyphenols inhibit acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation.
    Sugatani J; Fukazawa N; Ujihara K; Yoshinari K; Abe I; Noguchi H; Miwa M
    Int Arch Allergy Immunol; 2004 May; 134(1):17-28. PubMed ID: 15051936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
    Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
    J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
    Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
    Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the actions of some platelet-activating factor antagonists on platelets and aortic smooth muscles.
    Teng CM; Yu SM; Ko FN; Chen CC; Wang WC; Chen KY; Huang YL; Huang TF
    Eur J Pharmacol; 1991 Nov; 205(2):151-6. PubMed ID: 1812005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by diisoeugenol.
    Lin CH; Kuo YH; Lin YL; Teng CM
    J Pharm Pharmacol; 1994 Jan; 46(1):54-7. PubMed ID: 8201527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cryptolepine on collagen-induced aggregation and on the mobilization and metabolism of arachidonic acid by rabbit platelets.
    Oyekan AO; Ablordeppey SY
    Gen Pharmacol; 1993 Sep; 24(5):1285-90. PubMed ID: 8270188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.
    Komuro Y; Imanishi N; Uchida M; Morooka S
    Mol Pharmacol; 1990 Sep; 38(3):378-84. PubMed ID: 2402227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effect of 2-thienyl 2'-hydroxyphenyl ketone (C85) on platelet thromboxane formation.
    Chou TC; Hsu LY; Yen MH; Ding YA
    Thromb Res; 1996 Oct; 84(2):83-95. PubMed ID: 8897698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.
    Ostermann G; Hofmann B; Kertscher HP; Till U
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):713-8. PubMed ID: 2096302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
    Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
    Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet effects of some aporphine and phenanthrene alkaloids in rabbits and man.
    Teng CM; Hsueh CM; Chang YL; Ko FN; Lee SS; Liu KC
    J Pharm Pharmacol; 1997 Jul; 49(7):706-11. PubMed ID: 9255715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
    Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
    Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.